- Home
- FIBK vs VKTX Comparison
FIBK vs VKTX Comparison
Compare FIBK & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIBK
- VKTX
- Stock Information
- Founded
- FIBK 1879
- VKTX 2012
- Country
- FIBK United States
- VKTX United States
- Employees
- FIBK N/A
- VKTX N/A
- Industry
- FIBK Major Banks
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FIBK Finance
- VKTX Health Care
- Exchange
- FIBK Nasdaq
- VKTX Nasdaq
- Market Cap
- FIBK 3.5B
- VKTX 3.0B
- IPO Year
- FIBK 2010
- VKTX 2015
- Fundamental
- Price
- FIBK $31.89
- VKTX $29.72
- Analyst Decision
- FIBK Buy
- VKTX Strong Buy
- Analyst Count
- FIBK 7
- VKTX 12
- Target Price
- FIBK $34.86
- VKTX $86.42
- AVG Volume (30 Days)
- FIBK 1.1M
- VKTX 5.2M
- Earning Date
- FIBK 10-29-2025
- VKTX 10-22-2025
- Dividend Yield
- FIBK 5.90%
- VKTX N/A
- EPS Growth
- FIBK N/A
- VKTX N/A
- EPS
- FIBK 2.22
- VKTX N/A
- Revenue
- FIBK $935,300,000.00
- VKTX N/A
- Revenue This Year
- FIBK $10.42
- VKTX N/A
- Revenue Next Year
- FIBK $3.69
- VKTX N/A
- P/E Ratio
- FIBK $14.36
- VKTX N/A
- Revenue Growth
- FIBK N/A
- VKTX N/A
- 52 Week Low
- FIBK $22.95
- VKTX $18.92
- 52 Week High
- FIBK $36.77
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- FIBK 47.42
- VKTX 60.14
- Support Level
- FIBK $31.28
- VKTX $25.04
- Resistance Level
- FIBK $33.10
- VKTX $26.96
- Average True Range (ATR)
- FIBK 0.79
- VKTX 1.54
- MACD
- FIBK -0.23
- VKTX 0.67
- Stochastic Oscillator
- FIBK 22.51
- VKTX 98.12
About FIBK First Interstate BancSystem Inc. (DE)
First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism, and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.